Ashley McEvoy named Insulet CEO

Insulin pump maker Insulet names J&J veteran as new CEO, replacing Hollingshead

Insulet's sudden leadership change brings a seasoned medical technology executive to the helm, as the insulin pump maker says it expects to exceed Q1 revenue guidance and raise outlook.

Ashley McEvoy named Insulet CEO

McEvoy, the former leader of Johnson & Johnson’s medtech business, started immediately. Jim Hollingshead, who was CEO of Insulet for three years, resigned on Monday but will work as a consultant.

Ashley McEvoy named president and CEO at Insulet

New Insulet President and CEO Ashley McEvoy. [Image courtesy of Procter & Gamble]Insulet (Nasdaq:PODD) announced today that its board of directors appointed Ashley McEvoy as president and CEO, effective immediately. McEvoy, a longtime Johnson & Johnson MedTech executive, also joins the company’s board. She succeeds Jim Hollingshead in the corner office of the Acton, Massachusetts-based automated insulin delivery technology developer. Hollingshea…

Insulet Taps Johnson & Johnson Executive Ashley McEvoy as CEO Amid Strong Revenue Outlook

Former J&J MedTech chairman brings 30 years of healthcare leadership as Insulet eyes raised 2025 guidance. Strong Omnipod 5 momentum continues. Get details.